{"id": "1345724390550417408", "creation": 1609680671.0, "user_id": "621185967", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 1, "like_count": 0, "quote_count": 0}}, "quoted": "1345714058968911872", "text": "\u201c#India... granted emergency approval to @BharatBiotech's #COVAXIN but faced questions after taking the step without publishing efficacy data for the homegrown coronavirus #vaccine... A source [said] its effectiveness could be more than 60% with two doses.\u201d\ud83e\udd14#COVID19 #compliance https://t.co/VDc385dQNd", "first_save": 1634559108.199414, "hashtags": ["#INDIA", "#COVAXIN", "#VACCINE", "#COVID19", "#COMPLIANCE"]}